New York State Common Retirement Fund’s AbCellera Biologics ABCL Stock Holding History

New York State Common Retirement Fund’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-146,948	Closed	-$1.11M	–	3438
2023 Q1	$1.11M	Sell	146,948 -34,455	-19%	-$313K	﹤0.01%	1829
2022 Q4	$1.84M	Buy	181,403 +36,258	+25%	+$419K	﹤0.01%	1687
2022 Q3	$1.44M	Buy	145,145 +1,745	+1%	+$19.1K	﹤0.01%	1777
2022 Q2	$1.53M	Buy	+143,400	New	+$1.21M	﹤0.01%	1804
2022 Q1	–	Sell	-158,847	Closed	-$2.27M	–	3346
2021 Q4	$2.27M	Hold	158,847	–	–	﹤0.01%	1704
2021 Q3	$3.18M	Hold	158,847	–	–	﹤0.01%	1503
2021 Q2	$3.5M	Buy	+158,847	New	+$4.38M	﹤0.01%	1518

Other funds holding ABCL

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FFVM

Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

New York State Common Retirement Fund's ABCL Position: Q2 2023 in Review

New York State Common Retirement Fund sold out of AbCellera Biologics (ABCL) in Q2 2023, closing a stake of 146,948 shares — an estimated $1.11M sold.

New York State Common Retirement Fund first reported a position in ABCL in Q2 2021 and held it in 7 quarters. The position peaked at $3.5M in Q2 2021. 169 funds tracked by Wall St. Rank hold ABCL as of Q2 2023.

New York State Common Retirement Fund reported no remaining AbCellera Biologics position as of Q2 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 146,948 AbCellera Biologics shares in Q2 2023, an estimated $1.11M.
New York State Common Retirement Fund first reported a position in AbCellera Biologics in Q2 2021 and held it in 7 quarters.
New York State Common Retirement Fund's AbCellera Biologics position peaked at $3.5M in Q2 2021.
169 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2023.

Based on New York State Common Retirement Fund's 13F filing for Q2 2023, filed 7 Aug 2023.